Novo Nordisk A/S: Tresiba(R) (Insulin Degludec) And Ryzodeg(R) (Insulin Degludec/Insulin Aspart) Receive Positive Opinions From the European Regulatory Authorities

BAGSVAERD, DENMARK--(Marketwire - October 19, 2012) -

Company Announcement No 66 / 2012: http://hugin.info/2013/R/1650358/532183.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. 

Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1650358]